U.S. researchers have developed a genetic encryption system that uses chemical sequences to lock engineered cells, preventing the theft of high-value biological materials in the growing biotech industry.

Key Points

• The new security method uses a genetic combination lock that scrambles DNA, rendering cellular instructions non-functional until specific chemical inputs are applied.
• A biological keypad utilizes nine distinct chemicals to create 45 possible input combinations, requiring precise sequences to unscramble and activate the cells.
• Integrated safety mechanisms release toxins if the system is tampered with, providing a deterrent against unauthorized access.
• Ethical hacking tests demonstrated that random guessing resulted in a 0.2% success rate, nearly matching the system's theoretical security target of 0.1%.

Why it Matters

As the engineered cell market approaches an estimated $8 trillion valuation by 2035, protecting intellectual property from theft and smuggling has become a critical priority for biotech firms. This technology provides a robust framework for securing proprietary biological assets, potentially safeguarding massive investments in medical and industrial research.